Daisuke Ugamura, Michihiro Hosojima, Hideyuki Kabasawa, N. Tanabe, Yuta Yoshizawa, Yoshiki Suzuki, A. Saito, I. Narita
{"title":"胰高血糖素样肽-1受体激动剂dulaglutide治疗2型糖尿病维护性血液透析的疗效和安全性的探索性临床试验","authors":"Daisuke Ugamura, Michihiro Hosojima, Hideyuki Kabasawa, N. Tanabe, Yuta Yoshizawa, Yoshiki Suzuki, A. Saito, I. Narita","doi":"10.1186/s41100-022-00409-4","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":21028,"journal":{"name":"Renal Replacement Therapy","volume":" ","pages":"1-10"},"PeriodicalIF":0.9000,"publicationDate":"2022-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"An exploratory clinical trial on the efficacy and safety of glucagon-like peptide-1 receptor agonist dulaglutide in patients with type 2 diabetes on maintenance hemodialysis\",\"authors\":\"Daisuke Ugamura, Michihiro Hosojima, Hideyuki Kabasawa, N. Tanabe, Yuta Yoshizawa, Yoshiki Suzuki, A. Saito, I. Narita\",\"doi\":\"10.1186/s41100-022-00409-4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":21028,\"journal\":{\"name\":\"Renal Replacement Therapy\",\"volume\":\" \",\"pages\":\"1-10\"},\"PeriodicalIF\":0.9000,\"publicationDate\":\"2022-06-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Renal Replacement Therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1186/s41100-022-00409-4\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Renal Replacement Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s41100-022-00409-4","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
An exploratory clinical trial on the efficacy and safety of glucagon-like peptide-1 receptor agonist dulaglutide in patients with type 2 diabetes on maintenance hemodialysis